Evidence map›Paper›PMID 27790837›Full record

ArticleMicrobial biotechnology2017

Actinobacillus pleuropneumoniae grows as aggregates in the lung of pigs: is it time to refine our in vitro biofilm assays?

Yannick D N Tremblay, Josée Labrie, Sonia Chénier, Mario Jacques

Open access · goldAbstract read
In one paragraph

Article in Microbial biotechnology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Frontiers in veterinary science · 2023
    Review
  6. One Health-One Biofilm.Veterinary research · 2022
    Article
  7. Frontiers in veterinary science · 2021
    Article
  8. AnApplied and environmental microbiology · 2020
    Article
  9. Frontiers in microbiology · 2019
    Article
  10. Article
  11. Incorporation ofFrontiers in veterinary science · 2018
    Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Yannick D N TremblayGroupe de recherche sur les maladies infectieuses du porc, Faculté de médecine vétérinaire, Université de Montréal, St-Hyacinthe, QC, J2S 2M2, Canada.
Josée LabrieGroupe de recherche sur les maladies infectieuses du porc, Faculté de médecine vétérinaire, Université de Montréal, St-Hyacinthe, QC, J2S 2M2, Canada.
Sonia ChénierLaboratoire d'épidémiosurveillance animale du Québec, Ministère de l'Agriculture, des Pêcheries et de l'Alimentation du Québec, St-Hyacinthe, QC, J2S 7X9, Canada.
Mario JacquesGroupe de recherche sur les maladies infectieuses du porc, Faculté de médecine vétérinaire, Université de Montréal, St-Hyacinthe, QC, J2S 2M2, Canada.
Université de Montréal · CAMinistry of Agriculture, Fisheries and Food · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Actinobacillus pleuropneumoniae causes porcine pleuropneumonia and forms biofilms in vitro on abiotic surfaces; however, presence of biofilms during infections has not been documented. The aim of this study was to use a species-specific fluorescent oligonucleotide probe and confocal microscopy to localize A. pleuropneumoniae in the lungs of two naturally infected pigs. Actinobacillus pleuropneumoniae was detected by fluorescence in situ hybridization and observed to grow as aggregates (~30-45 μm) during a natural infection. As the A. pleuropneumoniae aggregates observed in porcine lungs differed from the biofilms grown on a solid surface obtained in vitro, we designed a new biofilm assay using agarose, a porous substrate, favouring the formation of aggregates. In this study, we described for the first time the mode of growth of A. pleuropneumoniae during a natural infection in pigs. We also propose an in vitro biofilm assay for A. pleuropneumoniae using a porous substrate which allows the formation of aggregates. This assay might be more representative of the in vivo situation, at least in terms of the size of the bacterial aggregates and the presence of a porous matrix, and could potentially be used to test the susceptibility of A. pleuropneumoniae aggregates to antibiotics and disinfectants.

Indexed as

Bacterial AdhesionActinobacillus InfectionsActinobacillus pleuropneumoniaeAnimalsBacteriological TechniquesBiofilmsIn Situ Hybridization, FluorescenceLungMicroscopy, ConfocalPleuropneumoniaSwineSwine Diseases

Identifiers

PMID27790837
PMCPMC5481545
OpenAlexW2542315660

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.